Tocilizumab, an arthritis drug also used to treat COVID-19 patients, is in short supply in Ontario hospitals. So doctors are being advised to ration the medication, also known as Actemra. Eric Sorensen looks at the challenges this shortage presents, and the race to find a solution.
- Experts urge national pharmaceutical security strategy amid drug shortage concerns
- Ontario science table recommends limiting use of COVID drug due to supply shortage